Joseph Sasadeusz

The Impact of Markers of HIV Infection on Change in Liver Stiffness in People With HIV and Hepatitis C Virus Co-infection After Treatment and Cure of Hepatitis C

Daniela K van Santen, Paul A Agius, Joseph Sasadeusz, Christopher K Fairley, William Sievert, Edward Gane, David Iser, Mark O'Reilly, Nicholas A Medland, Richard Moore, Margaret E Hellard, Jennifer F Hoy, Joseph S Doyle

Journal article  |  2020  |  JAIDS Journal of Acquired Immune Deficiency Syndromes

BACKGROUND: Markers of HIV disease severity are associated with increased liver fibrosis in HIV/Hepatitis C virus (HCV) co-infecte..

Primary herpes simplex virus type 2 hepatitis diagnosed during laparoscopy

Vivien Wai Yun Lai, Zaal Meher-Homji, Faye Liu, Joe Sasadeusz

Journal article  |  2020  |  The Lancet

Cat-Scratch Disease Masquerading as C3 Glomerulonephritis

Benjamin Sutu, Shio Yen Tio, Lucy C Fox, Joseph Sasadeusz, Piers Blombery, Moira J Finlay, Thomas D Barbour

Journal article  |  2020  |  Kidney International Reports

Hepatitis B related dilemmas in the renal unit

Stephen G Holt, Stephen Locarnini, Joe Sasadeusz

Journal article  |  2020  |  Nephrology

Testing for hepatitis B in dialysis patients is routine, but newer and more sensitive detection methods mean that there is sometim..

SUCCESSFUL IMPLEMENTATION OF INCREASED VIRAL RISK DONOR WAITING LIST FOR PRECONSENTED WAITLISTED RECIPIENTS IN VICTORIA

D Lee, N Seng, I Gramnea, F Hudson, R D'Costa, L Mcevoy, J Sasadeusz, B Gopal, J Kausman, R Masterson, K Paizis, J Kanellis, P Hughes, D Goodman, J Whitlam

Conference Proceedings  |  2020  |  NEPHROLOGY

An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial

James H McMahon, Jillian SY Lau, Janine Roney, Benjamin A Rogers, Jason Trubiano, Joseph Sasadeusz, James S Molton, Bradley Gardiner, Sue J Lee, Jennifer F Hoy, Allen Cheng, Anton Y Peleg

Journal article  |  2020  |  Trials

OBJECTIVES: Primary objective: To determine the efficacy of a candidate antiviral on time to virological cure compared to standard..

Micro-elimination of hepatitis C among people with HIV coinfection: declining incidence and prevalence accompanying a multi-center treatment scale-up trial.

JS Doyle, DK van Santen, D Iser, J Sasadeusz, M O'Reilly, B Harney, MW Traeger, J Roney, JC Cutts, AL Bowring, R Winter, N Medland, CK Fairley, R Moore, B Tee, J Asselin, C El-Hayek, JF Hoy, GV Matthews, M Prins, et al.

Journal article  |  2020  |  Clinical Infectious Diseases

BACKGROUND: Gay and bisexual men (GBM) are a key population affected by HIV and hepatitis C (HCV) co-infection. Providing HCV trea..

IMPLEMENTATION OF INCREASED VIRAL RISK DONOR WAITING LIST FOR PRE-CONSENTED WAITLISTED RECIPIENTS IN VICTORIA, AUSTRALIA

Nina Seng, Indra Gramnea, Fiona Hudson, Rohit D'Costa, Leanne McEvoy, Joe Sasadeusz, Basu Gopal, Joshua Kausman, Rosemary Masterson, Kathy Paizis, John Kanellis, Peter Hughes, David Goodman, John Whitlam, Darren Lee

Conference Proceedings  |  2020  |  TRANSPLANTATION

Very late-onset cytomegalovirus disease with ganciclovir resistance >15 years following renal transplantation

Sadid F Khan, Michelle K Yong, Monica A Slavin, Peter Hughes, Joseph Sasadeusz

Journal article  |  2020  |  Transplant Infectious Disease

Cytomegalovirus (CMV) infection is a significant cause of morbidity and mortality after solid organ transplantation. There has bee..

Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?

Jennifer Audsley, Anchalee Avihingsanon, Margaret Littlejohn, Scott Bowden, Gail Matthews, Christopher K Fairley, Sharon R Lewin, Joe Sasadeusz

Journal article  |  2020  |  JAIDS Journal of Acquired Immune Deficiency Syndromes

BACKGROUND: Tenofovir disoproxil fumarate (TDF) is effective in suppressing HIV and hepatitis B virus (HBV) replication in HIV-HBV..